-
Security Type
-
CAFES
-
Categories
-
Technology, Infrastructure, Healthcare & Medical, Community & Lifestyle
-
Min Investment
-
$100
-
Offering Date
-
July 20, 2021
-
Expected Close Date
-
April 30, 2023
-
Target Raise
-
$50.00K-$250.00K
-
No. Investors
-
100
-
Security Price
-
$1
- Number of Employees
- 1
- Cash
- $18,219
- Revenue
- $72,874
- Short Term Debt
- $90,306
- Cost of Goods
- $37,759
- Long Term Debt
- $74,700
- Net Income
- $5,872
Company Description
The AgeMeter® calculates functional age by noninvasively testing the body’s physiological biomarkers. With our new HealthMeter™ kit, we can analyze 16 physiological Covid-19 risk factors and indicators, as well. The AgeMeter can provide substantial income for medical practices, fitness centers, and hospital systems, and be a valuable tool for researchers, universities, and individuals interested in warding off the effects of aging.
Key Deal Facts
The only reputable, noninvasive device that calculates the age at which a person's body actually functions.
AgeMeter® already in North America, Central America, South America, Europe, Asia, Africa, & Oceania
AgeMeter® is used by doctors, researchers & individuals who can measure & monitor their aging-reversal health programs.
Endorsed by the world's top scientists, including Harvard geneticists Dr. George Church & Dr. David Sinclair.
Industry leader Neurohacker® used the AgeMeter® to validate its aging reversal nutraceutical in a March 2021 study.
Revenue from professional kit to medical practices & researchers app to individuals.
2021: Launch mobile app functional age test for individuals.
Management Team / Advisory Board Bios
Elliott Small, Founder and CEO
Harvard BA Biochemistry. 4 patents: 3 issued: Rapid Battery Charging, 1 pending: Aging Reversal Methods & Compositions. Chemist: Kraft Foods. Computer Programmer. A passion for a youthful life through aging reversal.
Dr. Edward Layne, Medical Director, MD, SCM
A graduate of Harvard College, Tulane Medical School, Harvard Medical School Post-grad, Dr. Layne currently serves as Medical Director at AgeMeter, and is the founder of 3 gastro and nutritional clinics, in the Atlanta, GA region.
Taylor Speegle, Chief Technology Officer
As CTO, Taylor is passionate about AgeMeter's mission to improve the quality of life for aging adults. He is also currently the managing partner of the award-winning MakerMonster design agency and is alumnus of Loyola Marymount Univ.
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation
Security Description
A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.